RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,053,000 | +74.5% | 717,618 | +30.7% | 0.34% | +39.6% |
| Q2 2022 | $9,197,000 | -44.0% | 549,055 | 0.0% | 0.24% | -31.8% |
| Q1 2022 | $16,433,000 | -2.5% | 549,055 | 0.0% | 0.36% | +20.9% |
| Q4 2021 | $16,861,000 | -51.2% | 549,055 | -45.1% | 0.30% | -43.0% |
| Q1 2021 | $34,570,000 | -16.8% | 1,000,000 | 0.0% | 0.52% | -10.3% |
| Q4 2020 | $41,560,000 | -2.4% | 1,000,000 | 0.0% | 0.58% | -25.4% |
| Q3 2020 | $42,590,000 | – | 1,000,000 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |